{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:29:54Z","timestamp":1790681394041,"version":"4.1.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T00:00:00Z","timestamp":1555718400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Pfizer Ltd"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oxford Biomedical Research Centre"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/infdis\/jiz178","type":"journal-article","created":{"date-parts":[[2019,4,14]],"date-time":"2019-04-14T11:07:19Z","timestamp":1555240039000},"source":"Crossref","is-referenced-by-count":38,"title":["Persistent Circulation of Vaccine Serotypes and Serotype Replacement After 5 Years of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine in the United Kingdom"],"prefix":"10.1093","author":[{"given":"Rama","family":"Kandasamy","sequence":"first","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"},{"name":"National Institute for Health Research Oxford Biomedical Research Centre, Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merryn","family":"Voysey","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"},{"name":"National Institute for Health Research Oxford Biomedical Research Centre, Oxford"},{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Collins","sequence":"additional","affiliation":[{"name":"Public Health England, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Berbers","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Robinson","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"},{"name":"National Institute for Health Research Oxford Biomedical Research Centre, Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Noel","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"},{"name":"National Institute for Health Research Oxford Biomedical Research Centre, Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harri","family":"Hughes","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"},{"name":"National Institute for Health Research Oxford Biomedical Research Centre, Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Ndimah","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"},{"name":"National Institute for Health Research Oxford Biomedical Research Centre, Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Gould","sequence":"additional","affiliation":[{"name":"Institute for Infection and Immunity, St George\u2019s, University of London"},{"name":"BUGS Bioscience, London Bioscience Innovation Centre, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Fry","sequence":"additional","affiliation":[{"name":"Public Health England, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Sheppard","sequence":"additional","affiliation":[{"name":"Public Health England, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamez","family":"Ladhani","sequence":"additional","affiliation":[{"name":"Public Health England, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D","family":"Snape","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"},{"name":"National Institute for Health Research Oxford Biomedical Research Centre, Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hinds","sequence":"additional","affiliation":[{"name":"Institute for Infection and Immunity, St George\u2019s, University of London"},{"name":"BUGS Bioscience, London Bioscience Innovation Centre, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Pollard","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford"},{"name":"National Institute for Health Research Oxford Biomedical Research Centre, Oxford"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,22]]},"reference":[{"key":"2019061004594921900_CIT0001","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2019061004594921900_CIT0002","unstructured":"UK Department of Health. Planned changes to the routine childhood immunisation programme. 2006. http:\/\/webarchive.nationalarchives.gov.uk\/20130107105354\/http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Lettersandcirculars\/Dearcolleagueletters\/DH_4128120. Accessed 28 May 2016."},{"key":"2019061004594921900_CIT0003","doi-asserted-by":"crossref","first-page":"e1001017","DOI":"10.1371\/journal.pmed.1001017","article-title":"Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study","volume":"8","author":"Flasche","year":"2011","journal-title":"PLoS Med"},{"key":"2019061004594921900_CIT0004","doi-asserted-by":"crossref","first-page":"e28435","DOI":"10.1371\/journal.pone.0028435","article-title":"Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and Wales","volume":"6","author":"Andrews","year":"2011","journal-title":"PLoS One"},{"key":"2019061004594921900_CIT0005","unstructured":"UK Department of Health, Joint Committee on Vaccination and Immunisation. JCVI meetings 2010.http:\/\/webarchive.nationalarchives.gov.uk\/20120907095400\/http:\/\/www.dh.gov.uk\/ab\/JCVI\/DH_107556#_5. Accessed 17 August 2018."},{"key":"2019061004594921900_CIT0006","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2019061004594921900_CIT0007","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1016\/j.vaccine.2014.03.017","article-title":"Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England","volume":"32","author":"Hoek","year":"2014","journal-title":"Vaccine"},{"key":"2019061004594921900_CIT0008","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/cid\/cit428","article-title":"Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial","volume":"57","author":"Dagan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019061004594921900_CIT0009","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1139\/cjm-2013-0614","article-title":"Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010\u20132012","volume":"59","author":"Demczuk","year":"2013","journal-title":"Can J Microbiol"},{"key":"2019061004594921900_CIT0010","doi-asserted-by":"crossref","unstructured":"Fry N , KapataiG, SheppardC, et al The fall and rise of serotype 19A in invasive pneumococcal disease: application of whole genome sequencing to investigate the recent rise in England and Wales. In: 10th International Symposium on Pneumococci and Pneumococcal Diseases,2016.","DOI":"10.26226\/morressier.5731f0d4d462b8029237f742"},{"key":"2019061004594921900_CIT0011","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/cid\/cix418","article-title":"Characteristics and serotype distribution of childhood cases of invasive pneumococcal disease following pneumococcal conjugate vaccination in England and Wales, 2006\u20132014","volume":"65","author":"Oligbu","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2019061004594921900_CIT0012","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1097\/MD.0000000000000335","article-title":"A cross-sectional observational study of pneumococcal carriage in children, their parents, and older adults following the introduction of the 7-valent pneumococcal conjugate vaccine","volume":"94","author":"Hamaluba","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2019061004594921900_CIT0013","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.vaccine.2013.08.062","article-title":"Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization pneumococcal carriage working group","volume":"32","author":"Satzke","year":"2013","journal-title":"Vaccine"},{"key":"2019061004594921900_CIT0014","volume-title":"Streptococcus pneumoniae: textbook in serotyping, virulence factors and enzyme-linked immunosorbent assay (ELISA) for measuring pneumococcal antibodies","author":"Statens Serum Institut","year":"2013"},{"key":"2019061004594921900_CIT0015","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.vaccine.2010.11.054","article-title":"Seroprevalence of IgG antibodies against 13 vaccine Streptococcus pneumoniae serotypes in the Netherlands","volume":"29","author":"Elberse","year":"2011","journal-title":"Vaccine"},{"key":"2019061004594921900_CIT0016","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2016"},{"key":"2019061004594921900_CIT0017","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2019061004594921900_CIT0018","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jpids\/pit057","article-title":"Impact of 13-valent pneumococcal conjugate vaccination on Streptococcus pneumoniae carriage in young children in Massachusetts","volume":"3","author":"Lee","year":"2014","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2019061004594921900_CIT0019","doi-asserted-by":"crossref","first-page":"e74906","DOI":"10.1371\/journal.pone.0074906","article-title":"Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes","volume":"8","author":"Grant","year":"2013","journal-title":"PLoS One"},{"key":"2019061004594921900_CIT0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.vaccine.2013.08.062","article-title":"Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization pneumococcal carriage working group","volume":"32","author":"Satzke","year":"2013","journal-title":"Vaccine"},{"key":"2019061004594921900_CIT0021","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1473-3099(17)30654-0","article-title":"Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial","volume":"18","author":"Goldblatt","year":"2018","journal-title":"Lancet Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiz178\/28788692\/jiz178.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"}],"deposited":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T09:40:46Z","timestamp":1607247646000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/advance-article\/doi\/10.1093\/infdis\/jiz178\/5475435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":21,"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz178","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"article-number":"jiz178"}}